SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to widespread user outages linked to an AWS issue, sparking frustration and concerns about reliability as users were unable to access accounts or trade. Despite the disruption, the stock price has shown surprising resilience, leading to discussions on market dynamics and potential short squeezes. Community members are debating the platform's dependence on a single server and comparing it to competitors, while some speculate about manipulation.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology ($GSIT) is trending due to news of a Cornell-led paper validating its Compute-In-Memory Gemini-I APU, showing comparable throughput to NVIDIA GPUs with significantly lower energy consumption. The stock is seeing increased interest as community members discuss its potential to compete with major players in the AI chip market, with some speculating about potential buyout offers. Community members are also discussing short squeezes.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle $ORCL is trending as analysts attend Oracle's analyst day, where executives outlined impressive targets for fiscal year 2030, including revenue and EPS well ahead of consensus. The community is actively discussing whether these targets are achievable, especially given concerns around AI infrastructure spending and profitability, while some are pointing towards a potential pullback.

Aventus Network

Aventus Network ($AVT) is trending as the community discusses its potential, particularly highlighting its integration with Polkadot for interoperability. Recent news includes the founder's feature in Forbes discussing the future of agentic AI and its implications for blockchain. Some investors are noting the low market cap relative to its technology and partnerships.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune ($REPL) is trending due to news of the FDA accepting the resubmission of its Biologics License Application for RP1, a melanoma treatment, leading to significant price movement and trading volume. Community discussions revolve around updated price targets, the potential for a short squeeze, and collaborations with major pharmaceutical companies. However, some traders express caution, citing the long PDUFA timeline and potential for a pump and dump.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Recent news regarding the company's CEO taking a board seat at TLPH is sparking community interest, especially given CRMD's strategic investment in TLPH. Some investors speculate about a potential acquisition, while others are focused on upcoming clinical data for TLPH's Niyad and its potential impact on CRMD's growth. Bullish sentiment seems to be driven by institutional buying and anticipation of upcoming earnings and guidance.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as the company explores rare earth production at its U.S. mining sites, potentially pivoting from steel to strategic minerals. Community members are weighing in on the CEO's vision, buyout possibilities, and the potential impact of this move on debt reduction and shareholder value. Some traders express concerns about the CEO's past performance and the sustainability of the recent surge.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending as discussions revolve around positive clinical data for their KRAS G12D inhibitor, offset by concerns about management spending and potential dilution; the community is weighing the promising ORR data against alternative treatments and the company's history, with some anticipating a potential breakout or buyout, while others express frustration with management and short selling.

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

PIMCO Dynamic Income Fund

PDI is experiencing volatility, driven by a recent downgrade and discussions around its premium to NAV and dividend coverage amid higher interest rates, sparking community debate on whether to buy the dip or brace for further declines. Community members are actively debating whether this dip represents a buying opportunity or signals deeper problems within the fund, with some citing attractive monthly payouts and high yield. The fund's reliance on leverage and high-yield credit in a challenging rate environment adds to the uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder...

Firefly Neuroscience rallied in its strongest session in more than a month on Tuesday after unveiling its new Clear Platform, a proprietary electroencephalogram (EEG) preprocessing technology built with Nvidia’s L40S GPU acceleration.The stock closed up 4.6% at $2.71 on Tuesday and added another 1.5% in after-hours trade.The medtech firm stated that the system achieves substantial processing speed gains of 60–80% while maintaining high signal quality, thereby enabling cleaner brainwave data for biomarker discovery and clinical research.&nbsp;Firefly stated that the platform could unlock new AI-driven insights to advance the diagnosis, treatment, and monitoring of neurological and psychiatric conditions.“Data quality is the foundation of clinical insight,” said Gil Issachar, Firefly’s Chief Technology Officer. “By combining our advanced preprocessing methods with Nvidia GPU acceleration, the Clear Platform represents the achievement of a key milestone along our path of building a foundation model of the human brain.”The launch comes months after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aiff-stock-soars-after-nvidia-connect-program-nod/ch5au23RuF">Firefly was accepted into the Nvidia Connect Program</a>, which provides participating companies with software development resources and technical training.CEO Greg Lipschitz said the rollout will play a central role in the company’s growth strategy, supporting efforts to discover and advance breakthrough brain biomarkers that can aid pharmaceutical R&amp;D, clinical trials, and patient care.Firefly develops AI-driven brain health tools and already holds FDA clearance for its Brain Network Analytics technology, which supports diagnosis and treatment monitoring for depression, dementia, anxiety, concussions, and ADHD.On Stocktwits, retail sentiment for Firefly was ‘extremely bullish’ amid an 11,700% surge in 24-hour message volume.One user described the stock as “a pound on the table” buy, calling it a potential multibagger in its early stages.<stembedurl>https://stocktwits.com/elgreg_2002/message/626646720</stembedurl>Another user predicted Firefly’s software could become the future of EEG diagnostics, noting that current brainwave readings are often noisy and time-consuming to interpret.&nbsp;With AI-driven clarity, they said, the company could cut delays in diagnosis and “be making a fortune.”<stembedurl>https://stocktwits.com/megamaven/message/626633235</stembedurl><a href="https://stocktwits.com/symbol/AIFF">Firefly Neuroscience’s stock</a> has risen 2.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)

Firefly Neuroscience Stock Scores Biggest Gain In Weeks On Nvidia Brain Platform Boost: Retail Says ‘Pound On The Table’ Buy

The surge followed the debut of Firefly’s Clear EEG technology, which promises faster, cleaner brain data for biomarker discovery. 

Equity

This Hidden-Gem Stock Is Skyrocketing on Nvidia News. Should You Buy It Now?

Firefly Neuroscience’s stock has skyrocketed over 200% in five days after joining Nvidia’s Partner Connect Program.

Shares of Firefly Neuroscience Inc. surged more than 30% on Wednesday afternoon, reaching their highest levels in over nine months.&nbsp;The micro-cap medtech firm’s stock was experiencing the largest jump in retail following among health care stocks on Stocktwits, with trading volume nearly 10 times the daily average of 7.29 million shares.The rally followed Firefly’s announcement on Tuesday that it had been accepted into the Nvidia Connect program, which provides participating companies with software development resources and technical training.Firefly plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics (BNA) technology platform.&nbsp;Developed with artificial intelligence and machine learning, BNA aims to enhance doctors’ insights into brain function and improve diagnostic accuracy for patients with neurological and mental disorders.That announcement sent Firefly shares rocketing 170% higher on Tuesday, marking their best session ever.On Stocktwits, Firefly — currently valued at just $88.6 million — has drawn increasing attention.&nbsp;Its retail following has soared by nearly 70% over the past month, while message volume has exploded by more than 168,000%.&nbsp;A poll on the platform asking whether the stock’s squeeze had real momentum saw 62% of respondents voting “Yes, $20+ soon,” while 28% called it a “pump and dump.”<figure class="image"><img style="aspect-ratio:1290/644;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AIFF_Stocktwits_Poll_On_Feb_12_0cf377b1b2.png" alt="AIFF Stocktwits Poll On Feb 12.png" width="1290" height="644"><figcaption>AIFF Stocktwits Poll On Feb 12</figcaption></figure>Short interest in Firefly has jumped from 2.6% at the start of the year to 26.7% by the end of January, according to Koyfin data.&nbsp;The company went public via a $45 million reverse merger with IT group WaveDancer last August, and shares have gained nearly 37% since then.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Stocktwits, Firefly — currently valued at just $88.6 million — has drawn increasing attention. | Image source: Getty Images

Firefly Neuroscience Leads Health Care Retail Follower Surge After Nvidia Connect Program Nod Sends Stock Soaring

The medtech firm plans to leverage these tools to build a human brain foundation model using its FDA-cleared Brain Network Analytics technology platform.

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. The company was founded in 1979 and is headquartered in Kenmore, NY.

Firefly Neuroscience Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

AIFF
Firefly Neuroscience Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AIFF News

AIFFFirefly Neuroscience Inc.